Evidence map›Paper›PMID 41167197›Full record

ArticleCell reports methods2025

SICyLIA-cTMT dissects redox proteome dynamics with high accuracy and depth at microgram scale.

Sergio Lilla, Samuel Atkinson, Sonja Radau, Ulla-Maja Bailey, Atul Shahaji Deshmukh, Jiska van der Reest, Joanna Kirkpatrick, Thomas MacVicar, Sara Zanivan

Abstract read
In one paragraph

Article in Cell reports methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sergio LillaCancer Research UK Scotland Institute, Glasgow G61 1BD, UK.
Samuel AtkinsonCancer Research UK Scotland Institute, Glasgow G61 1BD, UK; Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
Sonja RadauThermo Fisher Scientific GmbH, 63303 Dreieich, Germany.
Ulla-Maja BaileyCancer Research UK Scotland Institute, Glasgow G61 1BD, UK.
Atul Shahaji DeshmukhNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, 2200 Copenhagen, Denmark.
Jiska van der ReestCancer Research UK Scotland Institute, Glasgow G61 1BD, UK; VIB Center for Cancer Biology, 3000 Leuven, Belgium.
Joanna KirkpatrickThermo Fisher Scientific Stafford House, Boundary Way, Hemel Hempstead HP2 7GE, UK.
Thomas MacVicarCancer Research UK Scotland Institute, Glasgow G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK.
Sara ZanivanCancer Research UK Scotland Institute, Glasgow G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, UK; Department of Experimental Therapeutics, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: srzanivan@mdanderson.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cysteine oxidative modifications are critical signaling events regulating cellular functions, but their low abundance and dynamic nature pose technical challenges. We developed the SICyLIA-TMT workflow, which sequentially labels reduced and reversibly oxidized cysteines with light and heavy iodoacetamide (IAA) within the same sample. The inclusion of tandem mass tags (TMTs) enables simultaneous quantification of oxidative modification dynamics and protein levels across multiple conditions using micrograms of material. To improve the detection of low-abundance oxidized cysteines, a dedicated TMT channel serves as a carrier for heavy IAA-labeled peptides (SICyLIA-cTMT), enhancing quantification and enabling precise stoichiometry calculations. We demonstrate the workflow's applicability to cultured cells and full organs under stress. SICyLIA-cTMT achieves unprecedented depth and accuracy in redox proteome analysis while reducing mass spectrometry time. Combining SICyLIA-TMT with latest mass spectrometry technologies further halves the acquisition time without compromising coverage, improving throughput and enabling comprehensive studies of oxidative signaling.

Indexed as

ProteomeProteomicsAnimalsCysteineHumansIodoacetamideOxidation-ReductionTandem Mass SpectrometryCysteineIodoacetamideProteomecancerCP: biotechnologycysteine oxidationfibroblastsmass spectrometryobesityoxidative signalingpost-translational modificationredox proteomicsredox stress

Identifiers

PMID41167197
PMCPMC12664891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.